Eur Rev Med Pharmacol Sci 2023; 27 (9): 4232-4238
DOI: 10.26355/eurrev_202305_32333

Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder

K.-D. Zeng, G.-L. Wang, Y. Yuan, W. Zhang, X.-H. Huang, B. Hu

Department of Pediatrics, The Affiliated Yichun People’s Hospital of Yichun University, Yichun, Jiangxi, China. hutotoch38551@163.com


OBJECTIVE: The current research was designed to assess the efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.

PATIENTS AND METHODS: A total of 154 children with tic disorder co-morbid with attention deficit hyperactivity disorder admitted to our hospital from July 2019 to July 2022 were recruited and assigned to receive either methylphenidate hydrochloride plus haloperidol (observation group) or clonidine (experimental group), with 77 cases in each group. Outcome measures included clinical efficacy, Yale Global Tic Severity Scale (YGTSS) scores, Conners Parent Symptom Questionnaire (PSQ) scores, and adverse events.

RESULTS: Clonidine was associated with markedly higher clinical efficacy vs. methylphenidate hydrochloride plus haloperidol (p<0.05). Clonidine offered more significant mitigation of the tic disorder vs. methylphenidate hydrochloride plus haloperidol, as evinced by the lower kinetic tic scores, vocal tic scores, and total scores (p<0.05). Children exhibited markedly milder tic symptoms after clonidine monotherapy vs. those with dual therapy of methylphenidate hydrochloride and haloperidol, suggested by the lower scores of character problems, learning problems, psychosomatic disorders, hyperactivity/impulsivity, anxiety index, and hyperactivity index (p<0.05). Clonidine features a higher safety profile than methylphenidate hydrochloride plus haloperidol by reducing the incidence of adverse events (p<0.05).

CONCLUSIONS: Clonidine effectively alleviates tic symptoms, reduces attention deficit and hyperactivity/impulsivity in children with tic disorder co-morbid attention deficit hyperactivity disorder, and features a high safety profile.

Free PDF Download

To cite this article

K.-D. Zeng, G.-L. Wang, Y. Yuan, W. Zhang, X.-H. Huang, B. Hu
Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 9
Pages: 4232-4238
DOI: 10.26355/eurrev_202305_32333